A detailed history of Nantahala Capital Management, LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 126,362 shares of LUCD stock, worth $96,035. This represents 0.01% of its overall portfolio holdings.

Number of Shares
126,362
Previous 126,362 -0.0%
Holding current value
$96,035
Previous $103,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.67 - $1.04 $15,635 - $24,269
-23,336 Reduced 15.59%
126,362 $103,000
Q4 2023

Feb 14, 2024

SELL
$1.16 - $1.54 $9,786 - $12,992
-8,437 Reduced 5.34%
149,698 $211,000
Q3 2023

Nov 14, 2023

SELL
$1.17 - $1.65 $47,898 - $67,549
-40,939 Reduced 20.56%
158,135 $185,000
Q2 2023

Aug 14, 2023

SELL
$1.28 - $1.78 $80,115 - $111,410
-62,590 Reduced 23.92%
199,074 $276,000
Q1 2023

May 15, 2023

SELL
$1.17 - $1.77 $20,911 - $31,635
-17,873 Reduced 6.39%
261,664 $366,000
Q4 2022

Feb 14, 2023

SELL
$1.21 - $2.27 $8,342 - $15,651
-6,895 Reduced 2.41%
279,537 $380,000
Q3 2022

Nov 10, 2022

SELL
$1.53 - $3.45 $34,495 - $77,783
-22,546 Reduced 7.3%
286,432 $438,000
Q2 2022

Aug 15, 2022

SELL
$1.73 - $3.44 $11,134 - $22,139
-6,436 Reduced 2.04%
308,978 $698,000
Q1 2022

May 13, 2022

SELL
$2.85 - $5.24 $340,976 - $626,918
-119,641 Reduced 27.5%
315,414 $1.06 Million
Q4 2021

Feb 14, 2022

BUY
$4.87 - $11.76 $2.12 Million - $5.12 Million
435,055 New
435,055 $2.34 Million

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $29.3M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.